S&P 500   3,664.26 (+0.05%)
DOW   29,829.55 (+0.02%)
QQQ   302.91 (-0.18%)
AAPL   122.88 (+0.13%)
MSFT   214.50 (-0.79%)
FB   287.52 (+0.34%)
GOOGL   1,824.50 (+1.62%)
AMZN   3,206.01 (-0.44%)
TSLA   558.47 (-4.50%)
NVDA   541.47 (+1.10%)
BABA   261.40 (-0.99%)
CGC   28.21 (+5.85%)
GE   10.36 (+2.07%)
MU   68.90 (+2.71%)
AMD   93.82 (+1.28%)
T   28.91 (+0.14%)
NIO   46.97 (+3.55%)
F   9.16 (-0.87%)
ACB   10.83 (+11.08%)
NFLX   502.69 (-0.37%)
BA   221.75 (+4.10%)
GILD   61.01 (-0.18%)
DIS   153.01 (+2.39%)
S&P 500   3,664.26 (+0.05%)
DOW   29,829.55 (+0.02%)
QQQ   302.91 (-0.18%)
AAPL   122.88 (+0.13%)
MSFT   214.50 (-0.79%)
FB   287.52 (+0.34%)
GOOGL   1,824.50 (+1.62%)
AMZN   3,206.01 (-0.44%)
TSLA   558.47 (-4.50%)
NVDA   541.47 (+1.10%)
BABA   261.40 (-0.99%)
CGC   28.21 (+5.85%)
GE   10.36 (+2.07%)
MU   68.90 (+2.71%)
AMD   93.82 (+1.28%)
T   28.91 (+0.14%)
NIO   46.97 (+3.55%)
F   9.16 (-0.87%)
ACB   10.83 (+11.08%)
NFLX   502.69 (-0.37%)
BA   221.75 (+4.10%)
GILD   61.01 (-0.18%)
DIS   153.01 (+2.39%)
S&P 500   3,664.26 (+0.05%)
DOW   29,829.55 (+0.02%)
QQQ   302.91 (-0.18%)
AAPL   122.88 (+0.13%)
MSFT   214.50 (-0.79%)
FB   287.52 (+0.34%)
GOOGL   1,824.50 (+1.62%)
AMZN   3,206.01 (-0.44%)
TSLA   558.47 (-4.50%)
NVDA   541.47 (+1.10%)
BABA   261.40 (-0.99%)
CGC   28.21 (+5.85%)
GE   10.36 (+2.07%)
MU   68.90 (+2.71%)
AMD   93.82 (+1.28%)
T   28.91 (+0.14%)
NIO   46.97 (+3.55%)
F   9.16 (-0.87%)
ACB   10.83 (+11.08%)
NFLX   502.69 (-0.37%)
BA   221.75 (+4.10%)
GILD   61.01 (-0.18%)
DIS   153.01 (+2.39%)
S&P 500   3,664.26 (+0.05%)
DOW   29,829.55 (+0.02%)
QQQ   302.91 (-0.18%)
AAPL   122.88 (+0.13%)
MSFT   214.50 (-0.79%)
FB   287.52 (+0.34%)
GOOGL   1,824.50 (+1.62%)
AMZN   3,206.01 (-0.44%)
TSLA   558.47 (-4.50%)
NVDA   541.47 (+1.10%)
BABA   261.40 (-0.99%)
CGC   28.21 (+5.85%)
GE   10.36 (+2.07%)
MU   68.90 (+2.71%)
AMD   93.82 (+1.28%)
T   28.91 (+0.14%)
NIO   46.97 (+3.55%)
F   9.16 (-0.87%)
ACB   10.83 (+11.08%)
NFLX   502.69 (-0.37%)
BA   221.75 (+4.10%)
GILD   61.01 (-0.18%)
DIS   153.01 (+2.39%)
Log in
ARCA:TRXC

TransEnterix Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume3.03 million shs
Market Capitalization$43.82 million
P/E RatioN/A
Dividend YieldN/A
Beta2.43
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company's products include Senhance System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.13 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone919 765 8400
Employees160

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.53 million
Book Value$2.68 per share

Profitability

Net Income$-154,200,000.00
Net Margins-3,578.04%

Miscellaneous

Market Cap$43.82 million
Next Earnings DateN/A
OptionableOptionable
30 days | 90 days | 365 days | Advanced Chart

Receive TRXC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRXC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











TransEnterix (ARCA:TRXC) Frequently Asked Questions

What stocks does MarketBeat like better than TransEnterix?

Wall Street analysts have given TransEnterix a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but TransEnterix wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of TransEnterix's key competitors?

Who are TransEnterix's key executives?

TransEnterix's management team includes the following people:
  • Mr. Anthony Fernando, Pres, CEO & Director (Age 48, Pay $391.88k)
  • Mr. Todd M. Pope, Sr. Advisor (Age 55, Pay $552.43k)
  • Mr. Shameze Rampertab B.Sc. MBA, CA, CPA, Exec. VP & CFO (Age 53)
  • Mr. Joshua B. Weingard, Chief Legal Officer & Sec. (Age 47)
  • Mr. Mohan Nathan, VP of Global Marketing
  • Mr. Paul Ziegler, VP of Sales
  • Dr. Stephanie M. Fitts, VP of Clinical, Quality and Regulatory Affairs (Age 54)

What is TransEnterix's stock symbol?

TransEnterix trades on the ARCA under the ticker symbol "TRXC."

How do I buy shares of TransEnterix?

Shares of TRXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is TransEnterix?

TransEnterix has a market capitalization of $0.00 and generates $8.53 million in revenue each year. The company earns $-154,200,000.00 in net income (profit) each year or ($4.22) on an earnings per share basis. TransEnterix employs 160 workers across the globe.

What is TransEnterix's official website?

The official website for TransEnterix is www.transenterix.com.

How can I contact TransEnterix?

The company can be reached via phone at 919 765 8400.

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.